JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB314476

Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2]

Be the first to review this product! 리뷰 제출

|

(2 제품이 사용된 논문 )

Rabbit Recombinant Monoclonal N6-methyladenosine (m6A) antibody. Suitable for FRET, Dot and reacts with Nucleic Acid samples. Cited in 2 publications.

대체 명칭 보기

N6-methyladenosine, m6A

3 이미지
Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • Dot

Supplier Data

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : Hela (human cervical adenocarcinoma epithelial cell) total RNA Lane 2 : Hela (human cervical adenocarcinoma epithelial cell) mRNA Exposure time : 200s Blocking and diluting buffer and concentration : 5% NFDM/TBST

Fluorescence Resonance Energy Transfer - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • FRET

Supplier Data

Fluorescence Resonance Energy Transfer - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

A FRET-based assay was performed using 25 nm of each biotinylated oligo and ab314476 at a concentration range of 0.001-4.000 ug/ml. The Secondary antibody used was SA_D2 binding to antigen, GAR_tb binding to antibody at 1 : 100 dilution. Antigen : m6A RNA oligo, m6Am RNA oligo, Am RNA oligo, m6, 6A RNA oligo, m1A RNA oligo, m8A RNA oligo, m1G RNA oligo, m2G RNA oligo, A RNA oligo. Antigen concentration : 100 nmol/ml

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • Dot

Supplier Data

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : A-oligo Lane 2 : m6A-oligo Lane 3 : m6Am-oligo Lane 4 : Am-oligo Lane 5 : m6, 6A-oligo Lane 6 : m1A-oligo Lane 7 : m8A-oligo Lane 8 : m1G-oligo Lane 9 : m2G-oligo Exposure time : 5s Blocking and diluting buffer and concentration : 5% NFDM/TBST

관련 conjugated 항체와 다양한 조성의 항체 (1)

  • Carrier free

    Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPXVJ-1-2

Isotype

IgG

Carrier free

No

Applications

FRET, Dot

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

<p>This antibody targets both m6A and m6Am as seen in the FRET-based assay and Dot blot data, with a possible stronger preference for m6Am.</p>

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FRET" : {"fullname" : "Fluorescence Resonance Energy Transfer", "shortname":"FRET"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Nucleic Acid": { "FRET-species-checked": "testedAndGuaranteed", "FRET-species-dilution-info": "0.001-4 µg/mL", "FRET-species-notes": "<p></p>", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/5000", "Dot-species-notes": "<p></p>" } } }

제품 세부 정보

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

N6-methyladenosine (m6A) is a chemical modification present in RNA molecules specifically marking the adenosine base with a methyl group at the nitrogen-6 position. This modification weighing approximately 14 Da occurs in diverse eukaryotic species and influences RNA metabolism. m6A methylation can be detected using techniques like m6A dots blot or m6A ELISA. The modification is abundant in tissues like the brain and testis reflecting its critical role in varying cell types. Also m6A is known as a dynamic and reversible mark with its levels continuously adjusted by enzymes called writers (methyltransferases) erasers (demethylases) and readers (RNA-binding proteins).
Biological function summary

M6A methylation affects mRNA processing stability translation and decay. It integrates into large multi-protein complexes where it influences gene expression outcomes by affecting the RNA's interaction with the cellular machinery. This methylation modification acts as a regulatory signal that influences essential processes such as cell differentiation and circadian rhythms. Elucidating the biological functions of m6A involves studying how it affects RNA fate and its downstream gene regulatory networks.

Pathways

M6A modification is central to the mRNA metabolic pathway and the PI3K-Akt signaling pathway. It interacts with various proteins such as METTL3 an m6A methyltransferase which is vital for mediating m6A modification. It also interacts with YTH domain-containing proteins that recognize m6A marks influencing transcript dynamics and gene expression. The interplay of m6A with proteins in these pathways underlines its role in fine-tuning cellular processes and responses.

M6A modification has a significant impact on cancer and neurological disorders. In cancers alterations in m6A methylation patterns can promote oncogenic transformation and metastasis. m6A-related proteins such as FTO an m6A demethylase have shown connections to these pathways affecting cancer progression. In neurological disorders m6A impacts aspects of neural development and function and abnormalities in its regulation may contribute to diseases like Alzheimer's. Understanding the roles of m6A in diverse diseases can pave the way for novel therapeutic approaches.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

제품이 사용된 논문 (2)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Cell & bioscience 15:61 PubMed40380235

2025

The HNRNPC/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Ma,Haodong Li,Ziqi Zhao,Changchun Li,Man Wang,Lele Zhang,Yutong Zhao,Haipeng Su,Feng Wang,Jiai Hua

Clinics (Sao Paulo, Brazil) 80:100658 PubMed40245789

2025

Kynurenine promotes the immune escape of colorectal cancer cells via NAT10-mediated acC acetylation of PD-L1.

Applications

Unspecified application

Species

Unspecified reactive species

Zaibiao Wang,Manman Yin,Ruhang Zhou,Ming Li,Jie Peng,Zhengguang Wang
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com